522 related articles for article (PubMed ID: 15365653)
1. Calcium oxalate monohydrate binding protein: a diagnostic biomarker for calcium oxalate kidney stone formers.
Asokan D; Kalaiselvi P; Muhammed Farooq S; Varalakshmi P
Urol Res; 2004 Oct; 32(5):357-61. PubMed ID: 15365653
[TBL] [Abstract][Full Text] [Related]
2. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
Asokan D; Kalaiselvi P; Varalakshmi P
Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
[TBL] [Abstract][Full Text] [Related]
3. Epitaxial deposition of calcium oxalate on uric acid rich stone matrix is induced by a 29 kDa protein.
Srinivasan S; Kalaiselvi P; Varalakshmi P
Clin Chim Acta; 2006 Feb; 364(1-2):267-74. PubMed ID: 16139257
[TBL] [Abstract][Full Text] [Related]
4. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers.
Borghi L; Guerra A; Meschi T; Briganti A; Schianchi T; Allegri F; Novarini A
Kidney Int; 1999 Mar; 55(3):1041-50. PubMed ID: 10027942
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Metabolic Correlates of Calcium Oxalate Stone Subtypes: Implications for Etiology and Management.
Bamberger JN; Blum KA; Kan KM; Parkhomenko E; Gallante B; Gupta M
J Endourol; 2019 Sep; 33(9):755-760. PubMed ID: 31154910
[No Abstract] [Full Text] [Related]
6. Effects of urine dilution on quantity, size and aggregation of calcium oxalate crystals induced in vitro by an oxalate load.
Guerra A; Allegri F; Meschi T; Adorni G; Prati B; Nouvenne A; Novarini A; Maggiore U; Fiaccadori E; Borghi L
Clin Chem Lab Med; 2005; 43(6):585-9. PubMed ID: 16006253
[TBL] [Abstract][Full Text] [Related]
7. Clinical and biochemical profile of patients with "pure" uric acid nephrolithiasis compared with "pure" calcium oxalate stone formers.
Negri AL; Spivacow R; Del Valle E; Pinduli I; Marino A; Fradinger E; Zanchetta JR
Urol Res; 2007 Oct; 35(5):247-51. PubMed ID: 17786420
[TBL] [Abstract][Full Text] [Related]
8. Effects of urinary macromolecules on the nucleation of calcium oxalate in idiopathic stone formers and healthy controls.
Borghi L; Meschi T; Guerra A; Bergamaschi E; Mutti A; Novarini A
Clin Chim Acta; 1995 Jul; 239(1):1-11. PubMed ID: 7586581
[TBL] [Abstract][Full Text] [Related]
9. Papillary and nonpapillary calcium oxalate monohydrate renal calculi: comparative study of etiologic factors.
Pieras E; Costa-Bauzá A; Ramis M; Grases F
ScientificWorldJournal; 2006 Apr; 6():2411-9. PubMed ID: 17619710
[TBL] [Abstract][Full Text] [Related]
10. Tamm-Horsfall protein in recurrent calcium kidney stone formers with positive family history: abnormalities in urinary excretion, molecular structure and function.
Jaggi M; Nakagawa Y; Zipperle L; Hess B
Urol Res; 2007 Apr; 35(2):55-62. PubMed ID: 17345077
[TBL] [Abstract][Full Text] [Related]
11. Crystallization properties in urine from calcium oxalate stone formers.
Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
[TBL] [Abstract][Full Text] [Related]
12. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
[TBL] [Abstract][Full Text] [Related]
13. Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.
Khan SR; Glenton PA; Backov R; Talham DR
Kidney Int; 2002 Dec; 62(6):2062-72. PubMed ID: 12427130
[TBL] [Abstract][Full Text] [Related]
14. Calcium stone disease: a multiform reality.
Trinchieri A; Castelnuovo C; Lizzano R; Zanetti G
Urol Res; 2005 Jun; 33(3):194-8. PubMed ID: 15714335
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory activity of whole urine: a comparison of urines from stone formers and healthy subjects.
Ryall RL; Hibberd CM; Mazzachi BC; Marshall VR
Clin Chim Acta; 1986 Jan; 154(1):59-67. PubMed ID: 3943225
[TBL] [Abstract][Full Text] [Related]
16. Concentration of a potent calcium oxalate monohydrate crystal growth inhibitor in the urine of normal persons and kidney stone patients by ELISA-based assay system employing monoclonal antibodies.
Moghadam MF; Tandon C; Aggarwal S; Singla SK; Singh SK; Sharma SK; Varshney GC; Jethi RK
J Cell Biochem; 2003 Dec; 90(6):1261-75. PubMed ID: 14635198
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of factors involved in calcium stone formation.
Abraham PA; Smith CL
Miner Electrolyte Metab; 1987; 13(3):201-8. PubMed ID: 3627051
[TBL] [Abstract][Full Text] [Related]
18. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
[TBL] [Abstract][Full Text] [Related]
19. Study of calcium oxalate crystalluria on renal and vesical urines in stone formers and normal subjects.
Robert M; Boularan AM; Delbos O; Guiter J; Descomps B
Urol Int; 1998; 60(1):41-6. PubMed ID: 9519420
[TBL] [Abstract][Full Text] [Related]
20. Stone Composition Among First-Time Symptomatic Kidney Stone Formers in the Community.
Singh P; Enders FT; Vaughan LE; Bergstralh EJ; Knoedler JJ; Krambeck AE; Lieske JC; Rule AD
Mayo Clin Proc; 2015 Oct; 90(10):1356-65. PubMed ID: 26349951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
